COLUCID PHARMACEUTICALS
CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated stigmine platform that produces novel chemical entities for therapy of sleep/wake disorders, chronic pain, Alzheimer's disease, and psychiatric disorders. CoLucid Pharmaceuticals was founded in 2005 and is based in Research Triangle Park, North Carolina.
COLUCID PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2005-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.colucid.com
Total Employee:
1+
Status:
Active
Contact:
(919) 649-6184
Email Addresses:
[email protected]
Total Funding:
97.3 M USD
Technology used in webpage:
Font Awesome Amazon Google Maps Google Maps API ASP.NET Amazon Ohio Region Ninja Forms Entrust EV Entrust SSL Omniture SiteCatalyst
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Domain Associates
Domain Associates investment in Series C - CoLucid Pharmaceuticals
TVM Capital Life Science
TVM Capital Life Science investment in Series C - CoLucid Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series C - CoLucid Pharmaceuticals
Care Capital
Care Capital investment in Series C - CoLucid Pharmaceuticals
Auriga Partners
Auriga Partners investment in Series C - CoLucid Pharmaceuticals
Pearl Street Venture Funds
Pearl Street Venture Funds investment in Series C - CoLucid Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Series C - CoLucid Pharmaceuticals
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series C - CoLucid Pharmaceuticals
Domain Associates
Domain Associates investment in Venture Round - CoLucid Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Venture Round - CoLucid Pharmaceuticals
Official Site Inspections
http://www.colucid.com
- Host name: ec2-3-20-32-97.us-east-2.compute.amazonaws.com
- IP address: 3.20.32.97
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
